CS640 |
CS640 : Inhibitor of CAMK1D
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| CAMK1D |
|
|
Inhibitor
Cellular concentrations of well less than 1 uM should be considered prior to testing at 1 uM
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Potency Assay Off-Target:
Unselective within the CAMK1 family.
CS640 shows excellent selectivity in a Eurofins DiscoverX scree ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
NanoBRET confirms additional CAMK1 family targets:
CAMK1B IC50 8.2 nM
CAMK1A IC50 23 nM
CAMK1G IC50 ...
Potency Cellular
In Vitro
CAMK1D
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/acs.jmedchem.9b01803
In Vivo Validations
Mouse
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
8.3 h
Systemic clearance:
13.7 mL/min/Kg
Cmax:
503 ng/mL
Area Under the Curve::
2454 ng*h/mL
Volume of Distribution at Steady-State:
7.46 L/Kg
DOI Reference: 10.1021/acs.jmedchem.9b01803
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
5.9 h
Systemic clearance:
44%
Cmax:
387 ng/mL
Area Under the Curve::
5408 ng*h/mL
DOI Reference: 10.1021/acs.jmedchem.9b01803
Dose: 20 mg/Kg
Route of delivery:
Oral
Plasma half life:
5.9 h
Cmax:
2015 ng/mL
Area Under the Curve::
28923 ng*h/mL
Bioavailability:
118%
DOI Reference: 10.1021/acs.jmedchem.9b01803
Dose: 40 mg/Kg
Route of delivery:
Oral
Plasma half life:
6.2 h
Cmax:
3792 ng/mL
Area Under the Curve::
49220 ng*h/mL
Bioavailability:
100%
DOI Reference: 10.1021/acs.jmedchem.9b01803
Rat
Dose: 2 mg/Kg
Route of delivery:
Intravenous
Plasma half life:
7.7 h
Systemic clearance:
36.5 mL/min/Kg
Cmax:
391 ng/mL
Area Under the Curve::
913 ng*h/mL
Volume of Distribution at Steady-State:
18.5 L/Kg
DOI Reference: 10.1021/acs.jmedchem.9b01803
Dose: 10 mg/Kg
Route of delivery:
Oral
Plasma half life:
7.0 h
Cmax:
199 ng/mL
Area Under the Curve::
3058 ng*h/mL
Bioavailability:
67.5%
DOI Reference: 10.1021/acs.jmedchem.9b01803
Negative Control Compounds
CS640s
Notes: CS640s was tested in an in house kinase DSF Panel, showing no Tm shift on any kinase.
SMILES:
CC(c1nc(C(C)C)cc(Nc2c(C(N)=O)cnc(N3CCC[C@@H](C3)NC)n2)c1)C
Chemical Information
| Molecular Formula | C21H31N7O |
| SMILEs | CC(C)c1cc(Nc2nc(N3CCC[C@H](N)C3)ncc2C(N)=O)cc(C(C)C)n1 |
| InChI | InChI=1S/C21H31N7O/c1-12(2)17-8-15(9-18(26-17)13(3)4)25-20-16(19(23)29)10-24-21(27-20)28-7-5-6-14(22)11-28/h8-10,12-14H,5-7,11,22H2,1-4H3,(H2,23,29)(H,24,25,26,27)/t14-/m0/s1 |
| Molecular weight | 397.26 Da |
| AlogP | 2.8884000000000007 |
| HBond acceptors | 8 |
| HBond donors | 5 |
| Atoms | 60 |